HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS - ANVISA Registration 10269360471

Access comprehensive regulatory information for HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10269360471 and manufactured by QUIBASA QUÍMICA BÁSICA LTDA. The registration is held by QUIBASA - QUIMICA BASICA LTDA with validity until Jun 16, 2035.

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTIC DIVISION, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.